Results 81 to 90 of about 6,977,665 (334)

Improving the Yields in Higher Education: Findings from Lumina Foundation's State-Based Efforts to Increase Productivity in U.S. Higher Education [PDF]

open access: yes, 2015
In 2008, Lumina asked SPEC Associates (SPEC) to evaluate the foundation's grant making aimed at improving the productivity of higher education through statewide policy and program change.
Thad Nodine
core  

Proving Foundation Impact on Public Policy Empirically: The Case of the Robert Wood Johnson Foundation and Consumer Choice for Adults With Developmental Disabilities [PDF]

open access: yes, 2009
· Foundations that work on national public policy issues face challenges in demonstrating impact. · This case study of how the Robert Wood Johnson Foundation’s initiative to support choice of program provider for developmentally disabled adults uses some
Breihan, Ann Whitney
core   +3 more sources

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

open access: yesMolecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute   +17 more
wiley   +1 more source

Evolution and Modern Definitions of the Term «Grant» [PDF]

open access: yesProblemi Ekonomiki
The aim of the study is to theoretically substantiate the stages of evolution of the definition of «grant» and formulate recommendations for its clarification.
Poplavskyi Pavlo H.
doaj   +1 more source

LINC01116, a hypoxia‐lncRNA marker of pathological lymphangiogenesis and poor prognosis in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
The LINC01116 long noncoding RNA is induced by hypoxia and associated with poor prognosis and high recurrence rates in two cohorts of lung adenocarcinoma patients. Here, we demonstrate that besides its expression in cancer cells, LINC01116 is markedly expressed in lymphatic endothelial cells of the tumor stroma in which it participates in hypoxia ...
Marine Gautier‐Isola   +12 more
wiley   +1 more source

Linking grants to your publication

open access: yes, 2014
It is important that you add all appropriate grant information to relevant papers on Europe PMC to support: Grant Reporting Compliance with Funder open access policies Data Consistency     Resource Discovery Author Claiming There are a variety of routes that enable grants to be linked to papers in Europe PMC.
openaire   +2 more sources

Taxes, Federal Grants, Local Public Spending, and Growth [PDF]

open access: yes
In a dynamic model with both private and local public capital accumulation, this paper examines how federal and local income taxes, local consumption tax, and federal matching grants for local public consumption and local public investment affect the ...
Heng-fu Zou
core  

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

open access: yesMolecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg   +43 more
wiley   +1 more source

CALL 2025 : Publication Grant

open access: yesAmoxcalli
The Publication Grant of the Société des américanistes is intended to help publish books resulting from doctoral theses as well as any other scientific book, single-authored monographs or edited volumes. The manuscript must have been accepted by a publishing house, in France or abroad.
openaire   +2 more sources

Cell surface interactome analysis identifies TSPAN4 as a negative regulator of PD‐L1 in melanoma

open access: yesMolecular Oncology, EarlyView.
Using cell surface proximity biotinylation, we identified tetraspanin TSPAN4 within the PD‐L1 interactome of melanoma cells. TSPAN4 negatively regulates PD‐L1 expression and lateral mobility by limiting its interaction with CMTM6 and promoting PD‐L1 degradation.
Guus A. Franken   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy